The main objective of the present study is too prepared, characterized and evaluate and surfactant used as a carrier in solid dispersions for enhancing the dissolution rate of simvastatin. The feasibility of formulating solid dispersions of pure drug with gum and surfactant combination that enhanced dissolution rate was also investigated. Solid dispersions of simvastatin in gum: surfactant different polymer ratios were prepared by kneading method and evaluated for dissolution rate and efficiency. All the solid dispersions prepared gave rapid and higher dissolution of simvastatin when compared with pure drug. The DE60 was also increased from many folds in the case of pure drug and solid dispersions. Experimental design was applied systematically and determine the influence of the individual and combined effect on independent variables (X1) ratio and (X2) concentration of surfactants on the dependent variables percent dissolution efficiency at 60 min (%DE 60) and yield percent and optimized formulation selected and characterised by its UV, Differential scanning caloriemetery, Scanning electron microscopy and X-Diffraction studies and formulated into capsule dosage form. In conclusion, the result of this work to suggest that solid dispersion is a useful technique for enhancing the solubility and dissolution study of water insoluble drug.
INTRODUCTION
Today most challenging and important aspects in the pharma industries are related with strategies that improved and enhanced the solubility of poorly soluble drugs. Low solubility and dissolution rate of water insoluble drugs in the aqueous gastrointestinal fluids and cause insufficient bioavailability and especially for Class II category according to the Biopharmaceutics Classification System (BCS), the bioavailability may be enhanced by increasing the solubility and dissolution rate of the drug in the gastro-intestinal fluids. 1 The production of solid dispersions (SDs) is one of the acknowledged methods and used to enhance the aqueous solubility, thereby increasing the oral bioavailability and dissolution rate of drugs with aqueous low solubility 2, 3 . Greater stability, easy production, accurate dosage form and patient's perspective are the main reasons behind the preference of solid oral dosage form. Solid dispersions are one of the most successful strategies to improve the drug release profile of the water insoluble drugs 4, 5 . Simvastatin is a 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8ahexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4 hydroxy-6-oxo2Hpyran-2yl]ethyl]-1-naphthalenyl ester (BCS Class II) and cholesterol lowering agent and synthetically obtained from Aspergills terreus. It is a potent inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-Co A) Reductase which catalyzes the conversion of HMGCo A to mevalonate and inactive lactone is rapidly
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[74] CODEN (USA): JDDTAO metabolized to its corresponding beta-hydroxy acid (Simvastatin acid, SVA) after oral administration 6, 7 . Locust Bean Gum (LBG) (Carob Gum) is mainly consisting of the high molecular weight (approximately50,000-3,000,000)polysaccharides composed of galactomannans and obtained from the refined endosperm of seeds from the carobtree Ceretonia Siliqua and evergreen tree of the legume family and a white to yellowish white, nearly odourless powder and insoluble in most organic solvents. 8, 9 The Poloxamer polyols as a series of closely related block copolymers of ethylene oxide and propylene oxide conforming to the general formula O (C2H4O)a(C3H6O)b(C2H4O)H and group of block copolymer non-ionic surfactants and widely used as emulsifiers, solubilising agents, and suspension stabilizers in liquid, oral, topical, and parenteral dosage forms, wetting agents and plasticizers, and give better results for enhancing the solubility and dissolution of sparingly soluble drugs in solid dosage Poloxamer 188 (POL) is a non-ionic block copolymer chain and widely used for increasing the aqueous solubility of poorly water-soluble drugs and thus selected as a carrier for dissolution enhancement of a poorly water-soluble drug.
10, 11

MATERIAL AND METHODS
Material
The pure drug gift sample simvastatin received from Dr. Reddys' Pharmaceuticals' Ltd. Hyderabad. The hydrophilic surfactant Poloxamer 188 received as a gift sample from Sigma Aldrich Chem P Ltd. Mumbai and other chemicals i.e. ethanol, methanol, magnesium state, talc, lactose, disodium hydrogen orthophosphate and potassium dihydrogen orthophosphate were purchased from Loba Chemicals Mumbai, India.
Methods
Characterisation Parameters of pure drug
The pure drug sample was analysed by different means such as colour, odour and texture in order to prove the authenticity of the sample.
Solubility Determination of pure drug sample by UV spectroscopy
Absorption maxima of pure drug (λ max)
The pure drug sample was determined in different solvents by preparing the 10µg/ml solution of the drug and its absorption maxima was scanned by UV spectrophotometer between 200nm-400nm.
Preparation of Standard Plot in Distilled water
Pure drug sample (50mg) was dissolved in small amount of methanol (used as cosolvent), and diluted to 100ml of distilled water. 50ml of this solution was taken and diluted to 100ml with distilled water to prepare a stock solution of 250µg/ml as a stock solution and prepared aliquots of 0.1ml, 0.2ml, 0.3ml, 0.4ml, 0.5ml, 0.6ml and 0.7ml and transferred to 10ml volumetric flask and volume was made up to 10ml with distilled water. The absorbance of these solutions was measured at 239nm using distilled water as blank. 12 
Characterisation parameters of LBG/MLBG
Viscosity measurement
The viscous nature of locust bean gum and modified locust bean gum was measured at 37±1 o C by using searle type viscometer, DV-E-Brookfield Viscometer, with spindle number 62 at 10 rpm.
Angle of repose
The accurately weighed powder was taken in a funnel and height of a funnel was adjusted in such a way and its tip just touches the apex of the heap of powder and allowed to flow through funnel freely onto the surface. The diameter of the powder heap was measured and angle of repose was calculated by using the following equation:
Eq. 1
h Height of powder heap and r Radius of powder heap
Density
The loose bulk density (LBD) and tapped bulk density (TBD) of LBG/MLBG powder were determined. Powdered gum (2 gm) was poured into calibrated measuring cylinder (10 ml capacity) and noted initial volume and cylinder was allowed to fall under its own weight onto the hard surface from the height of 2.5 cm.
The tapping was then continued until no further change in volume was noted. LBD and TBD were calculated using the following equation: LBD = Wt of the powder/Volume of the packing Eq 2 TBD = Wt of the powder/Tapped volume of the packing Eq 3
Phase Solubility Studies
Solubility measurements were performed in which excess amount of pure drug (20mg) was added in 20ml of distilled water containing increasing concentrations of the MLBG (i.e. 0.25%, 0.5%, 1%, 1.25%, 1.5%, and 2%) in screw capped vials, sealed and shaken at room temperature for 48h on a water bath shaker and the samples were filtered and analysed spectrophometrically at 239nm.
Kneading method
Accurately weighed pure drug and MLBG in drug: polymer ratio of 1:2, 1:5, and 1:8 for 5 min using glass mortar and pestle and physical mixture was triturated by using a small volume of ethanol-water solution and form a thick paste and kneaded for 30 min respectively, dried at 45 o C in an oven. The dried mass was pulverized and passed through 60 mesh sieve size, weighed and transferred to airtight container and stored for further use 13, 14 .
Characterisation of Solid dispersions
Determination of percentage yield and drug content 15 
Drug content
Pure drug and solid dispersions equivalent to 10 mg dissolved in a suitable amount of methanol (25ml), filtered, suitably diluted with methanol and drug content was analyzed by UV spectrophotometer. 
Determination of solubility of solid dispersions
Simvastatin and different solid dispersions equivalent to 10 mg were weighed and added in 10 ml of Phosphate buffer pH 6.8 in screw capped vials and capped tightly, vortexed for 2 min and shaken at 37±2 o C in a temperature controlled water bath for 24 hrs. Resultant samples containing un-dissolved solid dispersions suspended in the screw capped vials were centrifuged and filtered, suitably diluted with phosphate buffer pH 6.8 and analyzed by UV spectrophotometer at 239.5 nm.
In-vitro drug release studies 15 Dissolution studies were conducted by using USP XXIV paddle method (apparatus 2) official in USP and Pure drug and solid dispersions equivalent to 10mg of simvastatin was added in 900ml phosphate buffer pH6.8 at speed of 100 rpm at temperature of 37±0.5 o C and pipette out 10ml solution was collected periodically and replaced with 10ml of freshly prepared dissolution medium and collected samples were analysed at 239.5nm by using UV-visible spectrophotometer against phosphate buffer pH6.8 used as blank.
Experimental Design
The various type of designs available for the optimization of dosage form and full factorial design was selected with its systematically study that effect upon the influence of the individual and combined effect of independent variables ratio (X 1 ) and concentration of surfactants (X 2 ) on the dependent variables percent dissolution efficiency at 60 min (%DE 60 ) and percent yield. In this design, two factors are evaluated each at three levels and experimental trials were performed at all nine possible combinations and statistical model incorporating interactive and polynomial terms is used to evaluate the response 16 .
Where, Y is the dependent variable, b 0 is the arithmetic mean response of the nine runs, and b 1 is the estimated coefficient for the factor X 1 and main effects (X 1 and X 2 ) represent the average result of changing one factor at a time from its low to high value and interaction terms (X 1 X 2 ) show the responsive changes when two factors are simultaneously changed. The polynomial terms ((X 1 ) 2 and (X 2 )
2 ) were included to investigate nonlinearity. 
Fourier transform infrared spectroscopy
Fourier transform infrared (FT-IR) spectroscopy was employed to characterize the possible interactions between the drug and the carrier in the solid state on an FT-IR spectrophotometer by the conventional KBr pellet method.
Powder x-ray diffraction analysis (XRD)
Powder XRD patterns of pure drug and optimized solid dispersion were recorded using diffractometer Philips 
Scanning electron microscopy (SEM)
The scanning electron microscopy (SEM) analysis was carried out on the samples of pure drug and the optimized solid dispersions were mounted onto the stubs using double-sided adhesive tape and then coated with a thin layer of gold palladium alloy (150-200A°).
Formulation of Optimized Batch into Capsules Dosage Form
The optimized solid dispersions were prepared by using the excipients as lactose were co-grinded in pestle and motor (except talc and magnesium stearate) and passed through mesh no. 60 and then added talc and magnesium stearate and mixed for 5 minutes and prepared hard gelatin capsules.
Evaluation Parameters of Capsules 7
General appearance
The general appearance of a capsule shell, its visual identification and over all 'elegance' is essential.
Weight variation test
The weight variation test was performed on weighing the intact the capsules individually and the average weight is determined. The tests requirements were met if none of the individual weighs are less than 90% or more than 110% of the average. If the original 20 did not meet these criteria, the individual net weighs are determined. These were averaged and differences were determined between individual net content and the average.
Disintegration test
In vitro disintegration time was determined using disintegration test apparatus. If the capsule floats on to the surface of the medium, a disc may be added. If the capsules adhere to the discs, attach a removable piece of stainless steel woven gauze with mesh apparatus of 2.00mm to the upper plate of the basket rack assembly and carry out the test omitting the discs. In this case, each capsule was placed in each of six tubes of apparatus and a disc was added to each tube that is three inches long, open at the top, and held against a 10 mesh screen at the bottom end of the basket rack assembly. The basket rack assembly was positioned in a one litre of distilled water at 37 o C ± 20 o C. The time taken for the capsule to disintegrate completely and pass through the screen was measured. Operate the apparatus for 30min unless otherwise directed.
Content uniformity
The content uniformity was performed by specified individual monographs. The requirements are met for the capsules if 9 of the 10 are specified potency range of 85 to 115% and tenth not outside 75 to 125%.
In vitro dissolution test
The dissolution studies were performed on the formulated capsule dosage forms in phosphate buffer pH 6.8. by using rotating paddle method and equivalent to 10mg of pure drug and capsule dosage form was added to 900 ml of phosphate buffer pH 6.8 (100rpm at 37±0.5 o C) and 10ml of aliquots were withdrawn at different time intervals and immediately filtered and replaced with 10ml of freshly prepared dissolution medium. The concentration of SIM was measured spectrophotometrically at 239.5nm and (%DE 60 ) & % drug released of the capsules was determined and compared with the pure drug.
Stability studies
Accelerated stability studies were performed on prepared solid dispersion capsule dosage form in amber coloured screw capped bottles and were checked as per ICH guidelines at 40±2ºC and 75± 5% RH up to one month. The capsules were kept in stability chamber. Samples were removed at regular intervals as initial, 7 days, 14 days, 21 days and 30 days and were analyzed for physical characterization, content uniformity and in vitro dissolution studies. The similarity factor (f2) was used as a basis to compare dissolution profiles. The dissolution profiles are considered to be similar when f2 is between 50 and100 and calculated by the given formula:
Eq. 6
Where, n is the dissolution time and Rj and Tj are the reference and test dissolution values at time t. (Morre Flamer equation).
Physiochemical Characterisation of Pure Drug
The sample of pure drug was characterised by its color, odor, taste and texture as given in officials (Indian pharmacopoeia). Similarly, It is white in color and crystalline nature and its melting point was 138.0 o C determined by Capillary method which is similar with literature value.
Maximum Absorption of Wavelength of Pure Drug
The maximum absorption wavelength of pure drug was observed in distilled water as shown in the given fig 1.
Figure 1: Scan graph of Simvastatin in Distilled water
Preparation of Standard Plot in Distilled water
The calibration plot of various concentrations of drug was found to be linear concentration range of 2.5 to 15µg/ml at 239.0 nm in distilled water as shown in the 
Characterisation parameters of LBG/MLBG
The characterised parameters of gum was determined by its viscosity, angle of repose and density parameters and excessive heating was performed in hot air oven and reduces its value that forms modified locust bean gum as shown in the given Table no.2. 
Determination of percentage yield and drug content
The drug content of the pure drug and solid dispersions was determined as 98.22-97.01%±0.01 and % Yield of prepared solid dispersions determined as increased from 72.6-83.2±0.24% and decreased at higher concentration ratios cause difficult in sieving due to higher polymersurfactants ratios and deviate values of standard deviation in percent yield.
Determination of solubility of solid dispersions
Solubility data of pure drug and different solid dispersions as shown in given Table 3 . 
In-vitro drug release studies
The In-vitro release of pure drug and different solid dispersions were determined as shown in Table 6 . and plotted the graph between % drug released vs. time as shown below from Fig. 4 -6 respectively. 
Experimental Design
The experimental designs were applied on the above prepared solid dispersions which is shown as below: The regression analysis results (p value) of the variables on percentage dissolution efficiency at 60 min and percent of yield of solid dispersion are shown in Table 5 .
Table 5: Result of Regression Analysis
The ANOVA results of solid dispersions are shown in Table 6 . According to p value, full model or reduced model can be selected, so in the present study, full model having both significant and non significant p values was used in obtaining dependent variables because the fitness of full model to the system is better than reduced model. Coefficients with one factor indicate the effect of that particular factor, while the coefficients with more than one factor and those with second-order terms represent the interaction between those factors and the quadratic nature of the phenomena, respectively. Positive sign of the term indicates positive (additive) effect, while negative sign indicates negative (antagonistic) effect of the factor on the response. It can be concluded from the equations that X 1 (drug: polymer ratio) shows the larger positive effect than term X 2 (concentration of surfactant PXM 188) on percentage dissolution efficiency at 60min and yield percent. The quadratic terms of X 1 and X 2 also had effect on percentage dissolution efficiency at 60 min and yield percent. Fig.7 and 8 shows the contour plots and response surface plots for percentage dissolution efficiency.
The reliability of the equations that describes the influence of factors on percentage dissolution efficiency at 60 min and % yield was assessed by preparing two additional check points solid dispersions (batch PXM 188 1 and PXM 188 2) in triplicate using the amount of X 1 and X 2 -1and +1 level. The experimental values and predicted values of each response are shown in The contour lines indicated that the higher the polymer and increasing the concentration of Poloxamer 188, the more significant in the dissolution enhancement. However, for yield percent, decrease at higher polymer ratio was observed, which may be attributed to difficulty of sieving when higher polymer ratio was used.
Characterization of Optimized Solid Dispersions
Differential scanning calorimetry
In the optimized preparation, due to higher polymer concentration ratio and uniform distribution of drug in the crust of polymer which indicates its miscibility of molten drug in polymer. Absence of sharp peak for the drug indicates that the drug is completely distributed homogenously in an amorphous nature state within the solid dispersions without any interaction as shown in the Fig. 9 . conc. 
Scanning electron microscopy (SEM)
Simvastatin was highly crystalline material and characterised by its needle shaped crystals and the crystals of solid dispersions of drug did not show any needle shaped crystals and shows uniform dispersion of the drug in the polymeric matrix of the polymer and surfactant was observed in the solid dispersions and that reduces the crystallinality nature of the drug and changes into an amorphous form as shown in the given Fig.12 . The optimized solid dispersions were filled into hard gelatin capsule shell and the final capsule dosage forms by using lactose, talc and other excipients were prepared and designated as C3. Data are expressed as mean ± S.D (n = 3) 
Evaluation Parameters of Capsules
CONCLUSION
Result was observed from the experimental design that significantly influences the dependent variables %DE 60 and %yield. Optimized value was formulated into capsule dosage form and characterised by its different parameters as it shows the crystalline nature of the drug and convert into amorphous form and dissolution rate increases was found to be 99% by adding the surfactant also improves the solubility of poorly soluble drug. The application of experimental study was used for the optimization for the formulation that helps in reaching the optimum point with corrected value in the shortest time. Pure drug C3
